Wednesday, April 6, 2011

PHARMACEUTICAL R&D PRODUCTIVITY - GETTING PAINFUL

A DECLINING TREND IN NEW DRUG APPROVAL IS FURTHER AGGRAVATED BY DECLINING PEAK SALES POTENTIAL